Silihan lan utang jangka dawa perusahaan: Vicarious Surgical Inc. (RBOT)

Tandha merek Vicarious Surgical Inc (RBOT)

Vicarious Surgical Inc. (RBOT) develops advanced robotic systems for minimally invasive surgery, providing the surgeon with a sense of presence inside the patient's body. This price chart shows that the company's shares reflect long-term debt at 0.01. The business model relies on selling unique systems to major hospitals seeking to minimize surgical risks. The startup is currently undergoing a rigorous certification phase and deploying the infrastructure necessary for the mass implementation of its technologies.

RBOT Vicarious Surgical Inc: Utang jangka dawa perusahaan ing interval 04.07.2022 - 07.03.2026
Produk asil prodhuksi Vicarious Surgical

To select high-quality assets, an investor must evaluate the long-term debt load, which measures the total volume of obligations with a maturity exceeding one year. Amid strict cash preservation and a pivot away from M&A, the absence of new loans within the long-term debt structure of Vicarious Surgical Inc. (RBOT) confirms a strategy of autonomous prototype development without increasing financial pressure.

Karo sapa Vicarious Surgical Inc. saingan

dexcom.com (DXCM) - Utang jangka dawa|PEN - Utang jangka dawa perusahaan|Silihan lan utang jangka dawa perusahaan NOVT (Novanta Inc)|HAE: Utang jangka dawa perusahaan|Inspire Medical Systems Inc (INSP) - Utang jangka dawa perusahaan|Utang jangka dawa perusahaan PROCEPT BioRobotics|conmed.com - Kewajiban jangka dawa|Utang jangka dawa perusahaan PLSE|INMD - Utang jangka dawa|Picard Medical Inc. - Kewajiban jangka dawa perusahaan|Utang jangka dawa perusahaan Surmodics Inc. SRDX|SENS: Kewajiban jangka dawa perusahaan|neuropace.com - Gedhene kewajiban jangka dawa|TCMD: Utang jangka dawa perusahaan|SNWV - Gunggunge utang jangka dawa|OM (Outset) - Utang jangka dawa perusahaan|Kewajiban jangka dawa perusahaan Electromed Inc (ELMD)|Kewajiban jangka dawa perusahaan LNSR (LENSAR, Inc.)|RCEL (avitamedical.com) - Silihan lan utang jangka dawa perusahaan|Utang jangka dawa perusahaan Profound Medical PROF|BDMD - Kewajiban jangka dawa perusahaan|EDAP Medical - Utang jangka dawa perusahaan|Utang jangka dawa Apyx Medical|ICCM: Utang jangka dawa perusahaan|Tanggungan utang jangka dawa perusahaan LUNG|TELA (TELA Bio Inc.) - Utang jangka dawa perusahaan|CytoSorbents Corp. (CTSO) - Gunggunge utang jangka dawa|Utang jangka dawa perusahaan SRTS|Kewajiban jangka dawa perusahaan Zynex Corp ZYXI|Utang jangka dawa perusahaan ECOR (electroCore)|Utang jangka dawa perusahaan Inspira Technologies Oxy B.H.N. Ltd. IINN|ICU - Utang jangka dawa perusahaan|IRIX: Utang jangka dawa perusahaan|INBS (ibs.inc) - Kewajiban jangka dawa perusahaan|Beyond Air - Silihan lan utang jangka dawa perusahaan|PFSA (Profusa Inc) - Utang jangka dawa perusahaan|Utang jangka dawa STRATA Skin SSKN|Utang jangka dawa perusahaan GlucoTrack (GCTK)|NanoVibronix Inc. (NAOV) - Tanggungan jangka dawa|Venus Concept Corp - Kewajiban jangka dawa perusahaan|Utang jangka dawa perusahaan Nuwellis Corp NUWE|Aethlon Medical - Utang jangka dawa perusahaan|Gunggunge utang jangka dawa Asensus Surgical, Inc. ASXC|Avinger (AVGR) - Utang jangka dawa perusahaan|Kewajiban jangka dawa BSGM (biosig.com)|Utang jangka dawa perusahaan Cutera, Inc|Kewajiban jangka dawa perusahaan Know Labs Corporation (KNW)|Utang jangka dawa perusahaan NARI|NVRO - Utang jangka dawa|Utang jangka dawa perusahaan ReShape Lifesciences Inc. RSLS|SILK: Tanggungan utang jangka dawa perusahaan